Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 295

1.

Maintaining Surgical Readiness While Deployed to Low-Volume Military Treatment Facilities: A Pilot Program for Clinical and Operational Sustainment Training in the Deployed Environment.

Gurney JM, Cole WC, Graybill JC, Shackelford SA, Via DK.

Mil Med. 2020 Jan 7;185(Supplement_1):508-512. doi: 10.1093/milmed/usz263.

PMID:
32074334
2.

Recurrent bacteremia: A 10-year retrospective study in combat-related burn casualties.

Aurora A, Le TD, Akers KS, Blyth DM, Graybill JC, Clemens MS, Chung KK, Rizzo JA.

Burns. 2019 May;45(3):579-588. doi: 10.1016/j.burns.2018.10.003. Epub 2018 Oct 29.

PMID:
30385059
3.

Burn Casualty Care in the Deployed Setting.

Driscoll IR, Mann-Salinas EA, Boyer NL, Pamplin JC, Serio-Melvin ML, Salinas J, Borgman MA, Sheridan RL, Melvin JJ, Peterson WC, Graybill JC, Rizzo JA, King BT, Chung KK, Cancio LC, Renz EM, Stockinger ZT.

Mil Med. 2018 Sep 1;183(suppl_2):161-167. doi: 10.1093/milmed/usy076.

PMID:
30189062
4.

Electric generation and ratcheted transport of contact-charged drops.

Cartier CA, Graybill JR, Bishop KJM.

Phys Rev E. 2017 Oct;96(4-1):043101. doi: 10.1103/PhysRevE.96.043101. Epub 2017 Oct 2.

PMID:
29347598
5.

The American Association for the Surgery of Trauma Severity Grade is valid and generalizable in adhesive small bowel obstruction.

Hernandez MC, Haddad NN, Cullinane DC, Yeh DD, Wydo S, Inaba K, Duane TM, Pakula A, Skinner R, Rodriguez CJ, Dunn J, Sams VG, Zielinski MD, Choudhry A, Turay D, Yune JM, Watras J, Widom KA, Cull J, Toschlog EA, Graybill JC; EAST SBO Workgroup.

J Trauma Acute Care Surg. 2018 Feb;84(2):372-378. doi: 10.1097/TA.0000000000001736.

PMID:
29117026
6.

Burns to the genitalia, perineum, and buttocks increase the risk of death among U.S. service members sustaining combat-related burns in Iraq and Afghanistan.

Clemens MS, Janak JC, Rizzo JA, Graybill JC, Buehner MF, Hudak SJ, Thompson CK, Chung KK.

Burns. 2017 Aug;43(5):1120-1128. doi: 10.1016/j.burns.2017.01.018. Epub 2017 Apr 21.

PMID:
28438352
7.

Multi-institutional, prospective, observational study comparing the Gastrografin challenge versus standard treatment in adhesive small bowel obstruction.

Zielinski MD, Haddad NN, Cullinane DC, Inaba K, Yeh DD, Wydo S, Turay D, Pakula A, Duane TM, Watras J, Widom KA, Cull J, Rodriguez CJ, Toschlog EA, Sams VG, Hazelton JP, Graybill JC, Skinner R, Yune JM; EAST SBO Workgroup: Martin D. Zielinski, MD; Nadeem N. Haddad, MD; Asad J. Choudhry, MBBS; Daniel C. Cullinane, MD; Kenji Inaba, MD; Agustin Escalante; D. Dante Yeh, MD; Salina Wydo, MD; David Turay, MD; Andrea Pakula, MD; Therese M. Duane, MD; Jill Watras, MD; Kenneth A. Widom, MD; John Cull, MD; Carlos J. Rodriguez, DO; Eric A. Toschlog, MD; Valerie G. Sams, MD; Joshua P. Hazelton, DO; John Christopher Graybill, MD, Ruby Skinner, MD, Ji-Ming Yune, MD.

J Trauma Acute Care Surg. 2017 Jul;83(1):47-54. doi: 10.1097/TA.0000000000001499.

PMID:
28422909
8.

Burn Shock and Resuscitation: Proceedings of a Symposium Conducted at the Meeting of the American Burn Association, Chicago, IL, 21 April 2015.

Serio-Melvin ML, Salinas J, Chung KK, Collins C, Graybill JC, Harrington DT, Herndon DN, Greenhalgh DG, Kramer GC, Lintner A, Mosier MJ, Nagpal A, Cancio LC.

J Burn Care Res. 2017 Jan/Feb;38(1):e423-e431. doi: 10.1097/BCR.0000000000000417.

PMID:
28009701
9.

Mechanical Response of Thermally Annealed Nafion Thin Films.

Frieberg BR, Page KA, Graybill JR, Walker ML, Stafford CM, Stafford GR, Soles CL.

ACS Appl Mater Interfaces. 2016 Dec 7;8(48):33240-33249. Epub 2016 Nov 23.

PMID:
27934151
10.

Care of the Burn Casualty in the Prolonged Field Care Environment.

Studer NM, Driscoll IR, Daly IM, Graybill JC.

J Spec Oper Med. 2015 Fall;15(3):86-93.

PMID:
26360361
11.

Antifungal wound penetration of amphotericin and voriconazole in combat-related injuries: case report.

Akers KS, Rowan MP, Niece KL, Graybill JC, Mende K, Chung KK, Murray CK.

BMC Infect Dis. 2015 Apr 15;15:184. doi: 10.1186/s12879-015-0918-8.

12.

Oxalate Nephropathy After Continuous Infusion of High-Dose Vitamin C as an Adjunct to Burn Resuscitation.

Buehner M, Pamplin J, Studer L, Hughes RL, King BT, Graybill JC, Chung KK.

J Burn Care Res. 2016 Jul-Aug;37(4):e374-9. doi: 10.1097/BCR.0000000000000233.

13.

Increased Education is Associated with Decreased Compliance in an Urban Multi-Ethnic Lupus Cohort.

Gross R, Graybill J, Wahezi D, Jordan NC, Putterman C, Blanco I.

J Clin Cell Immunol. 2014 Jun;5(3). pii: 215.

14.

FitKids360: design, conduct, and outcomes of a stage 2 pediatric obesity program.

Tucker JM, Eisenmann JC, Howard K, Guseman EH, Yee KE, DeLaFuente K, Graybill J, Roberts M, Murphy M, Saturley H, Peterson T.

J Obes. 2014;2014:370403. doi: 10.1155/2014/370403. Epub 2014 Aug 20.

15.

Impact of margin status and local recurrence on soft-tissue sarcoma outcomes.

Potter BK, Hwang PF, Forsberg JA, Hampton CB, Graybill JC, Peoples GE, Stojadinovic A.

J Bone Joint Surg Am. 2013 Oct 16;95(20):e151. doi: 10.2106/JBJS.L.01149.

PMID:
24132366
16.

Bayesian modeling of pretransplant variables accurately predicts kidney graft survival.

Brown TS, Elster EA, Stevens K, Graybill JC, Gillern S, Phinney S, Salifu MO, Jindal RM.

Am J Nephrol. 2012;36(6):561-9. doi: 10.1159/000345552. Epub 2012 Dec 5.

17.

Lymphocyte modulation with FTY720 improves hemorrhagic shock survival in swine.

Hawksworth JS, Graybill JC, Brown TS, Wallace SM, Davis TA, Tadaki DK, Elster EA.

PLoS One. 2012;7(4):e34224. doi: 10.1371/journal.pone.0034224. Epub 2012 Apr 30.

18.

A murine model of Cryptococcus gattii meningoencephalitis.

Thompson GR 3rd, Wiederhold NP, Najvar LK, Bocanegra R, Kirkpatrick WR, Graybill JR, Patterson TF.

J Antimicrob Chemother. 2012 Jun;67(6):1432-8. doi: 10.1093/jac/dks060. Epub 2012 Feb 29.

19.

Adiaspiromycosis causing respiratory failure and a review of human infections due to Emmonsia and Chrysosporium spp.

Anstead GM, Sutton DA, Graybill JR.

J Clin Microbiol. 2012 Apr;50(4):1346-54. doi: 10.1128/JCM.00226-11. Epub 2012 Jan 18. Review.

20.

Spinal cord stimulation for treatment of pain in a patient with post thoracotomy pain syndrome.

Graybill J, Conermann T, Kabazie AJ, Chandy S.

Pain Physician. 2011 Sep-Oct;14(5):441-5.

21.

Incidence of pulmonary embolus in combat casualties with extremity amputations and fractures.

Gillern SM, Sheppard FR, Evans KN, Graybill JC, Gage FA, Forsberg JA, Dunne JR, Tadaki DK, Elster EA.

J Trauma. 2011 Sep;71(3):607-12; discussion 612-3. doi: 10.1097/TA.0b013e3182282574.

PMID:
21908998
22.
23.

Efficacy of posaconazole as treatment and prophylaxis against Fusarium solani.

Wiederhold NP, Najvar LK, Bocanegra R, Graybill JR, Patterson TF.

Antimicrob Agents Chemother. 2010 Mar;54(3):1055-9. doi: 10.1128/AAC.01445-09. Epub 2010 Jan 11.

24.

Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, Harrison TS, Larsen RA, Lortholary O, Nguyen MH, Pappas PG, Powderly WG, Singh N, Sobel JD, Sorrell TC.

Clin Infect Dis. 2010 Feb 1;50(3):291-322. doi: 10.1086/649858.

25.

Room temperature pulsatile perfusion of renal allografts with Lifor compared with hypothermic machine pump solution.

Gage F, Leeser DB, Porterfield NK, Graybill JC, Gillern S, Hawksworth JS, Jindal RM, Thai N, Falta EM, Tadaki DK, Brown TS, Elster EA.

Transplant Proc. 2009 Nov;41(9):3571-4. doi: 10.1016/j.transproceed.2009.06.228.

PMID:
19917346
26.

Consensus statement on the management of invasive candidiasis in Intensive Care Units in the Asia-Pacific Region.

Hsueh PR, Graybill JR, Playford EG, Watcharananan SP, Oh MD, Ja'alam K, Huang S, Nangia V, Kurup A, Padiglione AA.

Int J Antimicrob Agents. 2009 Sep;34(3):205-9. doi: 10.1016/j.ijantimicag.2009.03.014. Epub 2009 May 5.

PMID:
19409759
27.

Inhaled voriconazole for prevention of invasive pulmonary aspergillosis.

Tolman JA, Wiederhold NP, McConville JT, Najvar LK, Bocanegra R, Peters JI, Coalson JJ, Graybill JR, Patterson TF, Williams RO 3rd.

Antimicrob Agents Chemother. 2009 Jun;53(6):2613-5. doi: 10.1128/AAC.01657-08. Epub 2009 Mar 16.

28.

The north and south of candidemia: Issues for Latin America.

Colombo AL, Thompson L, Graybill JR.

Drugs Today (Barc). 2008 Sep;44 Suppl A:1-34. Review.

PMID:
18810276
29.

Posaconazole as salvage treatment of invasive fungal infections in patients with underlying renal impairment.

Hachem RY, Langston AA, Graybill JR, Perfect JR, Pedicone LD, Patino H, Raad II.

J Antimicrob Chemother. 2008 Dec;62(6):1386-91. doi: 10.1093/jac/dkn401. Epub 2008 Oct 3.

PMID:
18835806
30.

Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant.

Alexander BD, Perfect JR, Daly JS, Restrepo A, Tobón AM, Patino H, Hardalo CJ, Graybill JR.

Transplantation. 2008 Sep 27;86(6):791-6. doi: 10.1097/TP.0b013e3181837585.

PMID:
18813103
31.

Evaluation of aminocandin and caspofungin against Candida glabrata including isolates with reduced caspofungin susceptibility.

Brzankalski GE, Najvar LK, Wiederhold NP, Bocanegra R, Fothergill AW, Rinaldi MG, Pattterson TF, Graybill JR.

J Antimicrob Chemother. 2008 Nov;62(5):1094-100. doi: 10.1093/jac/dkn304. Epub 2008 Jul 25.

32.

Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.

Segal BH, Herbrecht R, Stevens DA, Ostrosky-Zeichner L, Sobel J, Viscoli C, Walsh TJ, Maertens J, Patterson TF, Perfect JR, Dupont B, Wingard JR, Calandra T, Kauffman CA, Graybill JR, Baden LR, Pappas PG, Bennett JE, Kontoyiannis DP, Cordonnier C, Viviani MA, Bille J, Almyroudis NG, Wheat LJ, Graninger W, Bow EJ, Holland SM, Kullberg BJ, Dismukes WE, De Pauw BE.

Clin Infect Dis. 2008 Sep 1;47(5):674-83. doi: 10.1086/590566. Review.

33.

Voriconazole in the treatment of fungal eye infections: a review of current literature.

Hariprasad SM, Mieler WF, Lin TK, Sponsel WE, Graybill JR.

Br J Ophthalmol. 2008 Jul;92(7):871-8. doi: 10.1136/bjo.2007.136515. Review.

PMID:
18577634
34.

Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture.

Vallor AC, Kirkpatrick WR, Najvar LK, Bocanegra R, Kinney MC, Fothergill AW, Herrera ML, Wickes BL, Graybill JR, Patterson TF.

Antimicrob Agents Chemother. 2008 Jul;52(7):2593-8. doi: 10.1128/AAC.00276-08. Epub 2008 May 12.

35.

Therapeutic and prophylactic efficacy of aminocandin (IP960) against disseminated candidiasis in mice.

Najvar LK, Bocanegra R, Wiederhold NP, Lambros C, Najarian N, Patterson TF, Graybill JR.

Clin Microbiol Infect. 2008 Jun;14(6):595-600. doi: 10.1111/j.1469-0691.2008.01994.x. Epub 2008 Apr 5.

36.

Fungicidal versus Fungistatic: what's in a word?

Lewis JS 2nd, Graybill JR.

Expert Opin Pharmacother. 2008 Apr;9(6):927-35. doi: 10.1517/14656566.9.6.927. Review.

PMID:
18377336
37.

Assessment of serum (1->3)-beta-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis.

Wiederhold NP, Najvar LK, Vallor AC, Kirkpatrick WR, Bocanegra R, Molina D, Olivo M, Graybill JR, Patterson TF.

Antimicrob Agents Chemother. 2008 Mar;52(3):1176-8. Epub 2007 Dec 26.

38.

Antimicrobial resistance prevention initiative--an update: proceedings of an expert panel on resistance.

Moellering RC Jr, Graybill JR, McGowan JE Jr, Corey L; American Society for Microbiology.

Am J Infect Control. 2007 Nov;35(9):S1-23; quiz S24-6. Review.

PMID:
17980231
39.

Therapeutic efficacy of caspofungin alone and in combination with amphotericin B deoxycholate for coccidioidomycosis in a mouse model.

González GM, González G, Najvar LK, Graybill JR.

J Antimicrob Chemother. 2007 Dec;60(6):1341-6. Epub 2007 Oct 12.

PMID:
17934204
40.

Histological, CT, and intraoperative ultrasound appearance of hepatic tumors previously treated by laparoscopic radiofrequency ablation.

Mason T, Berber E, Graybill JC, Siperstein A.

J Gastrointest Surg. 2007 Oct;11(10):1333-8. Epub 2007 Jul 25.

PMID:
17653812
41.

Antimicrobial resistance prevention initiative--an update: proceedings of an expert panel on resistance.

Moellering RC Jr, Graybill JR, McGowan JE Jr, Corey L.

Am J Med. 2007 Jul;120(7):S4-25; quiz S26-8.

PMID:
17602911
42.

Posaconazole therapy for chronic refractory coccidioidomycosis.

Stevens DA, Rendon A, Gaona-Flores V, Catanzaro A, Anstead GM, Pedicone L, Graybill JR.

Chest. 2007 Sep;132(3):952-8. Epub 2007 Jun 15.

PMID:
17573510
43.

New guinea pig model of Cryptococcal meningitis.

Kirkpatrick WR, Najvar LK, Bocanegra R, Patterson TF, Graybill JR.

Antimicrob Agents Chemother. 2007 Aug;51(8):3011-3. Epub 2007 Jun 11.

44.

Aerosolized nanostructured itraconazole as prophylaxis against invasive pulmonary aspergillosis.

Alvarez CA, Wiederhold NP, McConville JT, Peters JI, Najvar LK, Graybill JR, Coalson JJ, Talbert RL, Burgess DS, Bocanegra R, Johnston KP, Williams RO 3rd.

J Infect. 2007 Jul;55(1):68-74. Epub 2007 Mar 13.

PMID:
17360039
45.

In vivo efficacy of anidulafungin and caspofungin against Candida glabrata and association with in vitro potency in the presence of sera.

Wiederhold NP, Najvar LK, Bocanegra R, Molina D, Olivo M, Graybill JR.

Antimicrob Agents Chemother. 2007 May;51(5):1616-20. Epub 2007 Feb 16.

46.

Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection.

Skiest DJ, Vazquez JA, Anstead GM, Graybill JR, Reynes J, Ward D, Hare R, Boparai N, Isaacs R.

Clin Infect Dis. 2007 Feb 15;44(4):607-14. Epub 2007 Jan 17.

PMID:
17243069
47.

Standardization of an experimental murine model of invasive pulmonary aspergillosis.

Sheppard DC, Graybill JR, Najvar LK, Chiang LY, Doedt T, Kirkpatrick WR, Bocanegra R, Vallor AC, Patterson TF, Filler SG.

Antimicrob Agents Chemother. 2006 Oct;50(10):3501-3.

48.

In-vivo dynamic deformation of the mitral valve anterior leaflet.

Sacks MS, Enomoto Y, Graybill JR, Merryman WD, Zeeshan A, Yoganathan AP, Levy RJ, Gorman RC, Gorman JH 3rd.

Ann Thorac Surg. 2006 Oct;82(4):1369-77.

PMID:
16996935
49.

Coccidioidomycosis.

Anstead GM, Graybill JR.

Infect Dis Clin North Am. 2006 Sep;20(3):621-43. Review.

PMID:
16984872
50.

Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt.

Anaissie EJ, Segal BH, Graybill JR, Arndt C, Perfect JR, Kleinberg M, Pappas P, Benjamin D, Rubin R, Aberg JA, Adderson EE, Adler-Shohet FC, Akan H, Akova M, Almyroudis NG, Alexander BD, Andes D, Arrieta A, Baddley JW, Barron MA, Belzberg H, Boucher HW, Boyce TG, Casadevall A, Chandrasekar PH, Cleary JD, Cordonnier C, Cornely OA, Cuenca-Estrella M, Daly JS, Daoura N, Denning DW, dePauw B, de Repentigny L, Dignani MC, Dismukes WE, Donnelly JP, Donowitz GR, Dupont B, Drusano G, Ellis M, Espinel-Ingroff A, Fishman JA, Fleming R, Forrest G, Ghannoum M, Goldman M, Grazziutti M, Greene JN, Greenberg RN, Gubbins PO, Hadley S, Herbrecht R, Hiemenz JW, Hope W, Hospenthal DR, Husain S, Ito JI, Jacobson RM, Johnson M, Keating MR, Kett DH, Knapp K, Kontoyiannis DP, Krcmery VC, Larsen R, Laverdiere M, Ljungman P, Lortholary O, Maertens J, Marriott D, Mattiuzzi G, McGinnis MR, Morris M, Nucci M, Odds FC, Pankey GA, Patterson T, Pfaller M, Razonable RR, Reboli AC, Rinaldi MG, Roberts GD, Rodriguez Tudela JL, Rotstein C, Ruhnke M, Schuster M, Shoham S, Sia IG, Siebel N, Silviera F, Singh N, Sobel J, Solomkin JS, Sorrell TC, Steinbach WJ, Temesgen Z, Tortorano A, Vartivarian S, VerWeij P, Viscoli C, Viviani MA, Walker RC, Wheat JL, Wiley J, Williamson P, Wingard JR, Yu VL, Zaoutis T.

Clin Infect Dis. 2006 Oct 15;43(8):1031-9. Epub 2006 Sep 13. No abstract available. Erratum in: Clin Infect Dis. 2007 Mar 15;44(6):894.

PMID:
16983616

Supplemental Content

Loading ...
Support Center